References
Quigley HA. Open-angle glaucoma. N Engl J Med 1993 Apr; 328(15): 1097–106
Adkins JC, Balfour JA. Brimonidine: a review of its pharmacological properties and clinical potential in the management of open-angle glaucoma and ocular hypertension. Drugs Aging 1998 Mar; 12(3): 225–41
Derick RJ, Robin AL, Walters TR, et al. Brimonidine tartrate: a one-month dose response study. Ophthalmology 1997 Jan; 104: 131–6
Serle JB. A comparison of the safety and efficacy of twice daily brimonidine 0.2% versus betaxolol 0.25% in subjects with elevated intraocular pressure. Surv Ophthalmol 1996 Nov; 41 Suppl. 1: S39–47
Schuman JS. Clinical experience with brimonidine 0.2% and timolol 0.5% in glaucoma and ocular hypertension. Surv Ophthalmol 1996 Nov; 41 Suppl. 1: 27–37
Gandolfi SA. The additive effect of brimonidine 0.2% BID compared with pilocarpine 2.0% TID in patients on beta-blocker monotherapy (abstract). Joint European Research Meeting in Ophthalmology and Vision (JERMOV); 1997 Oct 15–19: Montpelier
Allergan Limited. Alphagan®. ABPI Compendium of Data Sheets and Summaries of Product Characteristics 1998–99. London: Datapharm Publications Ltd: 54–5
Allergan Inc. Brimonidine tartrate. PDR Generics 1998. Montvale (NJ): Medical Economics: 375
Abel Jr RS, Abel AD. Ocular diseases. In: Speight TM, Holford NHG, editors. Avery’s drug treatment. 4th ed. Auckland: Adis International Limited, 1997: 581–605
Brooks AMV, Gillies WE. Ocular β-blockers in glaucoma management: clinical pharmacological aspects. Drugs Aging 1992 May–Jun; 2: 208–21
Patel SS, Spencer CM. Latanoprost: a review of its pharmacological properties, clinical efficacy and tolerability in the management of primary open-angle glaucoma and ocular hypertension. Drugs Aging 1996 Nov; 9: 363–78
Serle JB. Pharmacological advances in the treatment of glaucoma. Drugs Aging 1994 Sep; 5: 156–70
Balfour JA, Wilde MI. Dorzolamide: a review of its pharmacology and therapeutic potential in the management of glaucoma and ocular hypertension. Drugs Aging 1997 May; 10: 384–403
Rights and permissions
About this article
Cite this article
Brimonidine: a useful new topical treatment for glaucoma and ocular hypertension. Drugs Ther. Perspect 13, 1–4 (1999). https://doi.org/10.2165/00042310-199913010-00001
Published:
Issue Date:
DOI: https://doi.org/10.2165/00042310-199913010-00001